X-18894232-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000292.3(PHKA2):ā€‹c.3509T>Cā€‹(p.Met1170Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000224 in 1,210,290 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 97 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.00036 ( 0 hom., 19 hem., cov: 24)
Exomes š‘“: 0.00021 ( 0 hom. 78 hem. )

Consequence

PHKA2
NM_000292.3 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.78
Variant links:
Genes affected
PHKA2 (HGNC:8926): (phosphorylase kinase regulatory subunit alpha 2) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, and the hepatic isoform is encoded by this gene. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, which are encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9A, also known as X-linked liver glycogenosis. Alternatively spliced transcript variants have been reported, but the full-length nature of these variants has not been determined.[provided by RefSeq, Feb 2010]
PHKA2-AS1 (HGNC:44110): (PHKA2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010482669).
BP6
Variant X-18894232-A-G is Benign according to our data. Variant chrX-18894232-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 507443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000356 (40/112459) while in subpopulation AMR AF= 0.00112 (12/10672). AF 95% confidence interval is 0.000649. There are 0 homozygotes in gnomad4. There are 19 alleles in male gnomad4 subpopulation. Median coverage is 24. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 19 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PHKA2NM_000292.3 linkuse as main transcriptc.3509T>C p.Met1170Thr missense_variant 32/33 ENST00000379942.5
PHKA2-AS1NR_029379.1 linkuse as main transcriptn.553A>G non_coding_transcript_exon_variant 3/3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PHKA2ENST00000379942.5 linkuse as main transcriptc.3509T>C p.Met1170Thr missense_variant 32/331 NM_000292.3 P1
PHKA2-AS1ENST00000452900.5 linkuse as main transcriptn.553A>G non_coding_transcript_exon_variant 3/31

Frequencies

GnomAD3 genomes
AF:
0.000356
AC:
40
AN:
112459
Hom.:
0
Cov.:
24
AF XY:
0.000549
AC XY:
19
AN XY:
34619
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00112
Gnomad ASJ
AF:
0.00904
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000563
Gnomad OTH
AF:
0.000663
GnomAD3 exomes
AF:
0.000437
AC:
80
AN:
183151
Hom.:
0
AF XY:
0.000414
AC XY:
28
AN XY:
67677
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000438
Gnomad ASJ exome
AF:
0.00789
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000490
Gnomad OTH exome
AF:
0.00110
GnomAD4 exome
AF:
0.000210
AC:
231
AN:
1097831
Hom.:
0
Cov.:
30
AF XY:
0.000215
AC XY:
78
AN XY:
363267
show subpopulations
Gnomad4 AFR exome
AF:
0.0000379
Gnomad4 AMR exome
AF:
0.000284
Gnomad4 ASJ exome
AF:
0.00815
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000344
Gnomad4 OTH exome
AF:
0.000673
GnomAD4 genome
AF:
0.000356
AC:
40
AN:
112459
Hom.:
0
Cov.:
24
AF XY:
0.000549
AC XY:
19
AN XY:
34619
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00112
Gnomad4 ASJ
AF:
0.00904
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000563
Gnomad4 OTH
AF:
0.000663
Alfa
AF:
0.000464
Hom.:
19
Bravo
AF:
0.000446
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.000255
AC:
31
EpiCase
AF:
0.000164
EpiControl
AF:
0.000356

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxFeb 16, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Glycogen storage disease IXa1 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpApr 02, 2021- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 30, 2023This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
PHKA2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesNov 29, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenDec 01, 2022PHKA2: BP4, BS2; PHKA2-AS1: BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
9.1
DANN
Benign
0.66
DEOGEN2
Benign
0.21
T
FATHMM_MKL
Benign
0.41
N
LIST_S2
Benign
0.56
T
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.010
T
MetaSVM
Benign
-0.69
T
MutationAssessor
Benign
0.63
N
MutationTaster
Benign
0.94
N
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.24
Sift
Benign
0.55
T
Sift4G
Benign
0.58
T
Polyphen
0.0
B
Vest4
0.28
MVP
0.28
MPC
0.25
ClinPred
0.0055
T
GERP RS
-1.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.097
gMVP
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150445034; hg19: chrX-18912350; API